Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 36Carcinoma, Renal Cell 16Prostatic Neoplasms 10Neoplasm Metastasis 10Leukemia, Myeloid, Acute 9Carcinoma, Non-Small-Cell Lung 9Uveal Melanoma 8Myelodysplastic Syndromes 8Leukemia, Lymphocytic, Chronic, B-Cell 7Clear-cell metastatic renal cell carcinoma 7Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Hematologic Neoplasms 6Triple Negative Breast Neoplasms 5Sarcoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Multiple Myeloma 5Hodgkin Disease 5Breast Neoplasms 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Lymphoma, Follicular 4Histiocytoma, Malignant Fibrous 4Gastrointestinal Stromal Tumors 4Burkitt Lymphoma 4Urinary Bladder Neoplasms 3Urethral Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Sugars 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngeal Diseases × CTLA-4 Antigen × Clear all
NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
24 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡